Empagliflozin mitigates metabolic dysfunction‐associated steatotic liver disease by reducing de novo lipogenesis in a mouse model of lipoatrophic diabetes

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Sarra Smati, Thibaud Sotin, Perrine Deniel, Simon Ducheix, Michael Joubert, Lucie Arnaud, Samy Hadjadj, Bertrand Cariou, Cédric Le May, Xavier Prieur
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Diabetes, Obesity and Metabolism
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Similar Items